Keyword Analysis & Research: gilead investor relations
Keyword Research: People who searched gilead investor relations also searched
Search Results related to gilead investor relations on Search Engine
-
Gilead Sciences, Inc. - Investor Relations
https://investors.gilead.com/overview/default.aspx
WEBQuick Links. Stock Information. View current and historic stock prices, analyst information. Financial Information. Download quarterly earnings reports, supplementary data, SEC filings. Corporate Governance. Learn about our governance guidelines, code of ethics, Board of Directors.
DA: 56 PA: 87 MOZ Rank: 52
-
Gilead Sciences Announces Fourth Quarter and Full Year 2023 …
https://www.gilead.com/news-and-press/press-room/press-releases/2024/2/gilead-sciences-announces-fourth-quarter-and-full-year-2023-financial-results
WEBFeb 6, 2024 · Gilead Sciences Announces Fourth Quarter and Full Year 2023 Financial Results. Product Sales Excluding Veklury Increased Year-Over-Year by 7% for Full Year 2023. Biktarvy Sales Increased Year-Over-Year by 14% for Full Year 2023. Oncology Sales Increased Year-Over-Year by 37% for Full Year 2023.
DA: 18 PA: 55 MOZ Rank: 51
-
Gilead Sciences, Inc. - Gilead Sciences Announces Fourth …
https://investors.gilead.com/news/news-details/2023/Gilead-Sciences-Announces-Fourth-Quarter-and-Full-Year-2022-Financial-Results/default.aspx
WEBFeb 2, 2023 · FOSTER CITY, Calif.-- (BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2022. “2022 marked Gilead’s strongest full year growth in our base business since HCV sales peaked in 2015.
DA: 20 PA: 32 MOZ Rank: 53
-
Gilead Sciences Announces Third Quarter 2023 Financial Results
https://investors.gilead.com/news/news-details/2023/Gilead-Sciences-Announces-Third-Quarter-2023-Financial-Results/default.aspx
WEBNov 7, 2023 · During the third quarter of 2023, Gilead repaid $2.3 billion of debt, paid dividends of $953 million and repurchased $300 million of common stock. Additionally, Gilead issued senior unsecured notes in an aggregate principal amount of $2.0 billion.
DA: 21 PA: 92 MOZ Rank: 58
-
Gilead Sciences to Release Fourth Quarter & Full Year 2023 …
https://www.gilead.com/news-and-press/press-room/press-releases/2024/1/gilead-sciences-to-release-fourth-quarter--full-year-2023-financial-results-on-tuesday-february-6-2024
WEBJan 23, 2024 · At 5:00 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’s fourth quarter and full year 2023 financial results and provide a business update. A live webcast will be available on the Investor Relations section of www.gilead.com and will be archived there for one year.
DA: 73 PA: 28 MOZ Rank: 73
-
Gilead Sciences Announces Second Quarter 2022 Financial Results
https://investors.gilead.com/news/news-details/2022/Gilead-Sciences-Announces-Second-Quarter-2022-Financial-Results/default.aspx
WEBAug 2, 2022 · Biktarvy Sales Increased 28% Year-Over-Year to $2.6 billion Oncology Sales Increased 71% Year-Over-Year to $527 million Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the second quarter of 2022.
DA: 47 PA: 24 MOZ Rank: 11
-
Gilead Sciences Announces Third Quarter 2021 Financial Results
https://www.gilead.com/news-and-press/press-room/press-releases/2021/10/gilead-sciences-announces-third-quarter-2021-financial-results
WEBOct 28, 2021 · Gilead has updated its full-year guidance, and now expects: Total product sales between $26.0 billion and $26.3 billion, compared to $24.4 billion and $25.0 billion previously, reflecting year-to-date results and our updated expectations for …
DA: 10 PA: 64 MOZ Rank: 28
-
Gilead Sciences Announces First Quarter 2022 Financial Results
https://www.gilead.com/news-and-press/press-room/press-releases/2022/4/gilead-sciences-announces-first-quarter-2022-financial-results
WEBApr 28, 2022 · As of March 31, 2022, Gilead had $6.8 billion of cash, cash equivalents and marketable debt securities compared to $7.8 billion as of December 31, 2021. During the first quarter of 2022, Gilead generated $1.8 billion in operating cash flow, which includes the cash outflow related to the $1.25 billion legal settlement.
DA: 52 PA: 1 MOZ Rank: 1
-
Gilead Sciences Announces First Quarter 2023 Financial Results
https://www.gilead.com/news-and-press/press-room/press-releases/2023/4/gilead-sciences-announces-first-quarter-2023-financial-results
WEBApr 27, 2023 · First Quarter 2023 Product Gross Margin, Operating Expenses and Effective Tax Rate. Product gross margin was 77.8% for the first quarter of 2023 compared to 78.2% for the same period in 2022. Non-GAAP product gross margin was 86.2% for the first quarter of 2023 compared to 87.4% in the same period in 2022.
DA: 95 PA: 67 MOZ Rank: 14
-
Gilead Sciences to Release Fourth Quarter & Full Year 2023 …
https://www.businesswire.com/news/home/20240123115550/en/Gilead-Sciences-to-Release-Fourth-Quarter-Full-Year-2023-Financial-Results-on-Tuesday-February-6-2024/
WEBJan 23, 2024 · [email protected]. Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its fourth quarter and full year 2023 financial results and guidance will be released on Tue.
DA: 82 PA: 74 MOZ Rank: 5